June 29, 2020 / 1:58 PM / 6 days ago

BRIEF-Intercept Pharmaceuticals Executive Says Strongly Believe The FDA's Decision Was Premature

June 29 (Reuters) - Intercept Pharmaceuticals Inc:

* EXECUTIVE SAYS WE STRONGLY BELIEVE THE FDA’S DECISION WAS PREMATURE

* EXECUTIVE SAYS WE VERY MUCH DISAGREE ABOUT THE CRL BASED ON THE EFFECTIVENESS OF THE TREATMENT

* EXECUTIVE SAYS THERE IS NO ADDITIONAL PLANNED INTERIM ANALYSIS AT THIS POINT

* EXECUTIVE SAYS DOES NOT HAVE CLARITY ABOUT WHAT KIND OF EFFICACY DATA FDA IS LOOKING FOR

* EXECUTIVE SAYS FDA DIDN’T EVER SAY THE DRUG WAS UNAPPROVABLE

* EXECUTIVE SAYS FDA IS NOT REQUESTING ANY ADDITIONAL STUDY Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below